Skip to main content
URGN logo

URGN

UroGen Pharma Ltd.

$39.80

1.56%

Trade Ideas Performance

Latest Closed Trade Idea

$39.80

1.56%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

10

Social

20

About

Events of UroGen Pharma Ltd. (URGN)

UroGen Pharma's stock has been influenced by several events in the past six months. Top-line results from the Phase 3 UTOPIA trial for UGN-103 were reported in November 2025. The Journal of Urology published the ENVISION trial results for ZUSDURI in late March 2026. BlackRock disclosed a new 5.2% passive stake in the company on March 31, 2026. UroGen launched its 'LG-UTUC Luminaries' initiative in April 2026. Jefferies Financial Group upgraded UroGen Pharma's shares to a "strong-buy" rating in April 2026. Oppenheimer raised its price target on the stock in May 2026. UroGen Pharma reported its first-quarter 2026 financial results on May 6, 2026.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
UroGen Pharma Ltd. (URGN) Live Stock Price, Chart & Financial News | Edge Hound